Dr. Fredrick T Klingbeil, MD Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine Medicare: Accepting Medicare Assignments Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
News Archive
TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.
In patients with obesity and type 2 diabetes, a meal schedule that includes a high-energy breakfast promotes weight loss, improves diabetes and decreases the need for insulin, new research from Israel reports.
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
"At the Global Fund [to Fight AIDS, Tuberculosis and Malaria], we launched a new funding model this week that is built to capitalize on open interaction and information flow," Global Fund Executive Director Mark Dybul writes in the Huffington Post's "The Big Push" blog, adding, "With more open dialogue between cooperative partners, we can more effectively confront and ultimately defeat these terrible diseases."
› Verified 2 days ago